中国循环杂志2024,Vol.39Issue(12) :1244-1248.DOI:10.3969/j.issn.1000-3614.2024.12.015

非酒精性脂肪性肝病与心血管代谢疾病关系的研究进展

Research Advances in the Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular-related Metabolic Diseases

蔡永祥 黄会慧 都欢 周龙 陶剑虹
中国循环杂志2024,Vol.39Issue(12) :1244-1248.DOI:10.3969/j.issn.1000-3614.2024.12.015

非酒精性脂肪性肝病与心血管代谢疾病关系的研究进展

Research Advances in the Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular-related Metabolic Diseases

蔡永祥 1黄会慧 1都欢 1周龙 2陶剑虹2
扫码查看

作者信息

  • 1. 电子科技大学医学院,成都 610054
  • 2. 四川省医学科学院 四川省人民医院(电子科技大学附属医院) 心血管病研究所 心血管内科,成都 610072
  • 折叠

摘要

非酒精性脂肪性肝病(NAFLD)是较常见的慢性肝病,我国NAFLD患病率约为29.2%.大量临床研究表明,NAFLD与肥胖、血脂异常、糖尿病、高血压等心血管代谢疾病关系密切,并且NAFLD是动脉粥样硬化性心血管疾病(ASCVD)的独立危险因素,心血管疾病是NAFLD患者的主要死因.本文对NAFLD及代谢功能障碍相关性脂肪性肝病(MAFLD)与ASCVD及心血管代谢疾病之间的关系进行综述,并探讨了胰岛素抵抗、氧化应激、炎症等相关病理生理机制,以期为降低NAFLD相关的心血管代谢疾病风险提供思路.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease,with a prevalence of about 29.2% in China.A large number of clinical studies have shown that NAFLD is closely related to cardiovascular-related metabolic diseases such as obesity,dyslipidemia,diabetes mellitus,hypertension,etc.,and NAFLD is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD),and cardiovascular disease is the leading cause of death in patients with NAFLD.This article reviews the relationship between NAFLD and metabolic dysfunction-associated fatty liver disease (MAFLD) with ASCVD and related metabolic diseases,and discusses the related pathophysiological mechanisms such as insulin resistance,oxidative stress,and inflammation,aiming to provide practical recommendations for reducing the risk of NAFLD-associated cardiovascular disease.

关键词

非酒精性脂肪性肝病/动脉粥样硬化性心血管疾病/血脂异常/糖尿病/高血压

Key words

non-alcoholic fatty liver disease/atherosclerotic cardiovascular disease/dyslipidemia/diabetes/hypertension

引用本文复制引用

出版年

2024
中国循环杂志
中国医学科学院

中国循环杂志

CSTPCDCSCD北大核心
影响因子:2.803
ISSN:1000-3614
段落导航相关论文